is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
The improvement in technology in the Hematology automated cell counters greatly improved the diagnosis of blood diseases that is reflected on the patient's management. Hematology automated blood cell counters have a differential counting capacity, providing either a three-parts or a five- to seven-parts differential count with the ability to measure nucleated red cells and immature granulocytes. They can also flag and reject abnormal cells. With the use of the advanced technology, anemias can now be accurately detected and classified using the MCV and RDW. These new technologies allowed the emergence of new parameters like, the Hemoglobin Distribution Width (HDW) indicative of the degree of hypochromia, and the Monocyte Distribution Width (MDW) that identifies and classifies Infections and Sepsis.